BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $361 | +0.6% | 51 | 0.0% | 0.00% | – |
Q2 2023 | $359 | -15.5% | 51 | 0.0% | 0.00% | – |
Q1 2023 | $425 | -27.4% | 51 | 0.0% | 0.00% | – |
Q4 2022 | $585 | -41.5% | 51 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 51 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | – | 51 | +628.6% | 0.00% | – |
Q3 2021 | $0 | – | 7 | +40.0% | 0.00% | – |
Q2 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |